MODULE 1 GENE THERAPY UNIT

Morris Plains, NJ

​

Owner:        Novartis Pharmaceuticals

Architect:    Ewing Cole

​

Surepath completed a three-year assignment with our long-term client, Novartis, managing their new gene therapy project.  This project was critical to Novartis' growth in bio-pharmaceuticals and included state of the art clean rooms.  Surepath was responsible for overall project management, coordination, scheduling, and managing equipment validation.